Marker Therapeutics (MRKR) Non Operating Investment Income (2013 - 2014)
Marker Therapeutics (MRKR) posted quarterly Non Operating Investment Income of -$94640.0 for Q3 2014, up 43.8% year-over-year from -$65814.6 in Q3 2013, and up 43.8% quarter-over-quarter from -$168392.0 in Q3 2013.
Marker Therapeutics (MRKR) Non Operating Investment Income (2013 - 2014) Analysis & Trends
Marker Therapeutics (MRKR) has reported Non Operating Investment Income for 2 consecutive years, with -$94640.0 the latest figure, recorded in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Marker Therapeutics | 27.04 Mn | 15.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | -94,640.00 |
| Sep 30, 2014 | -94,640.00 |
| Sep 30, 2013 | -168,392.00 |
| Sep 30, 2013 | -168,392.00 |